Company Directory

Real-world mental health and dementia data platform for drug development

Akrivia Health is a software company providing a real-world data and AI platform for neuroscience research and drug development. Its dataset of de-identified electronic health records from 6.3 million patients across 20 NHS Trusts covers mental health and dementia conditions, enriched through proprietary natural language processing. Commercial applications include health economics and outcomes research, clinical trial patient recruitment, pharmacovigilance, and drug discovery target identification.

Specialist CRO for rare disease drug development and commercialisation

TMC Pharma Services is a contract research organisation specialising in drug development support for rare and orphan diseases. The company serves small and mid-sized biotech and biopharma clients across the full development lifecycle, providing regulatory affairs, clinical development, pharmacovigilance, medical services, quality management, and drug commercialisation services including marketing authorisation holder functions. Therapeutic areas of focus include oncology, rare neurological disorders, respiratory disease, and haematology.

Takeda's UK clinical development and drug discovery operations

Takeda UK encompasses the British operations of Takeda Pharmaceutical Company, one of the world's largest biopharmaceutical companies. The London-based Takeda Development Centre Europe leads clinical development, regulatory affairs, and medical affairs across oncology, neuroscience, gastrointestinal disease, rare diseases, and vaccines. Takeda Cambridge, based at Cambridge Science Park, conducts target-based drug discovery research in CNS disorders and metabolic diseases.

Full-service CRO and pharmacovigilance services for biopharma

Ergomed is a global contract research organisation providing clinical development, pharmacovigilance, and regulatory compliance services to the pharmaceutical and biotechnology industries. Operating across more than 100 countries, the group manages Phase I to IV clinical trials with particular depth in oncology and rare disease programmes. Its portfolio of service brands includes Ergomed Clinical Research, PrimeVigilance for post-marketing drug safety, and ADAMAS Consulting for GxP auditing.

Global clinical research organisation providing consultant support for trials

Momentum Pharma is a company providing clinical trial consultants and functional service provider solutions to biotech, pharmaceutical and CRO clients globally. Operating as an alternative to traditional full-service CROs, it supplies embedded clinical research associates, programme managers and regulatory specialists on a flexible basis, with expertise spanning oncology, rare disease, haematology and neuroscience. The company operates across 45 countries and was recognised with a King's Award for Enterprise for international trade in 2022.

Global CRO delivering outsourced clinical development and safety services

ICON plc is a contract research organisation providing outsourced clinical development and commercialisation services to pharmaceutical, biotechnology, and medical device companies worldwide. The company supports the full product development lifecycle, from early-phase studies through to post-market safety monitoring. UK operations are based across sites in Swansea, Reading, and Livingston, with the Swansea hub specialising in clinical research services including pharmacovigilance.

Specialist oncology CRO for early and late phase clinical trials

Theradex (Europe) Limited is the European arm of Theradex Oncology, a US-founded CRO with over 40 years specialising in oncology clinical development. The company provides full-service clinical trial management for pharma and biotech sponsors across early and late phase studies, with expertise in oncology, haematology, and immunology. Services include protocol design, regulatory support, site selection, monitoring, and data management. Theradex holds a long-standing contract with the US National Cancer Institute for clinical trials monitoring.

Bioanalytical and toxicology laboratory for pharmaceutical and clinical research

Analytical Services International is a GLP and GCP-compliant bioanalytical laboratory providing mass spectrometry-based services to pharmaceutical companies and contract research organisations. Services include assay development, small molecule clinical bioanalysis, pharmacokinetic sample analysis, and pharmacovigilance support across drug discovery and clinical trial phases. The company also operates internationally recognised immunosuppressant drug measurement proficiency testing schemes serving over 800 participating laboratories worldwide, and provides therapeutic drug monitoring services to clinicians.

Pharmacovigilance consultancy for clinical and post-marketing drug safety

Drive Phase PV Limited is a UK pharmacovigilance consultancy providing drug safety and device-vigilance services across clinical development and post-marketing settings. Services include PV system design, safety database management, signal detection, risk management plans, QPPV provision, periodic safety reporting, and audit support. The company works with clients ranging from early-phase clinical trial sponsors to major pharmaceutical companies, with particular expertise in oncology and biologics.

Full-service CRO for pharmaceutical and biotech clinical trials

Acceler8 Clinical Research is a contract research organisation providing clinical trial management and support services to pharmaceutical, biotechnology, and medical device companies. Services span clinical development, data management, regulatory affairs, clinical quality assurance, and project management across multiple therapeutic areas including oncology, neurology, cell and gene therapy, and rare disease. The company operates as a trading name of The Pharmaceutical Code Company Limited, a subsidiary of Arithmos.

Full-service CRO specialising in oncology and early-phase trials

Pivotal CRO is a full-service contract research organisation providing end-to-end clinical development support across all trial phases, from first-in-human to Phase III. The company offers clinical operations, regulatory affairs, data management, biostatistics, medical monitoring, pharmacovigilance, and patient recruitment services. Pivotal has particular depth in oncology and advanced therapy programmes, working primarily with biotech and pharma sponsors across European and global trial networks.

UK's largest early-phase clinical CRO specialising in first-in-human trials

Hammersmith Medicines Research is one of the largest early-phase contract research organisations in Europe, specialising in Phase I and early Phase II clinical trials of investigational medicinal products. Operating from a purpose-built 145-bed facility in West London, HMR provides fully integrated services from study design through to clinical study report. The unit holds MHRA Phase I accreditation and licences for controlled drugs, radiolabelled compounds, and investigational medicinal products.